GSK to make 1bn doses of pandemic vaccine adjuvant
The adjuvant could reduce the amount of vaccine protein required per dose and enhance the immune response
Read More
Tag: adjuvant
Roche’s Kadcyla shows promise in early breast cancer
Roche has announced that its antibody drug conjugate Kadcyla cut the risk of disease recurrence when given after neoadjuvant treatment and surgery to certain breast cancer patients with residual disease.
Read More
NICE rejects Opdivo for preventing melanoma recurrence
NHS funding for use of Bristol-Myers Squibb’s Opdivo as an adjuvant treatment for resected stage III and IV melanoma is being blocked by the National Institute for Health and Care Excellence.
Read More
NICE rejects adjuvant use of Perjeta post-surgery
The National Institute for Health and Care Excellence says adjuvant use of Roche’s breast cancer drug Perjeta in patients who have had surgery is not cost effective for the NHS.
Read More
